Logo

John Boyce

Nov 02, 2015

Exosome Diagnostics has appointed John Boyce as its Chief Executive Officer. Boyce is a co-founder of GnuBio and served as president and CEO of the company until its acquisition by Bio-Rad, after which he headed the Bio-Rad Digital Biology Center. Prior to his work at GnuBio, Boyce served as head of business development and scientific collaborations at Helicos. He was also senior director of commercial development at Parallele Biosciences and senior director of sales and marketing at Sequenom.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.